Dennis Smith, DO
Family Medicine · Tupelo, MSNPI 1245279918
Payments from drug & device makers
Across 65 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$274
- Pfizer$162
- Johnson & Johnson$138
- AbbVie$86
- Novo Nordisk$69
- Inspire Medical Systems, Inc.$55
- plus $409 from 14 others
What the payments were for
- Food & beverage$1,193100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $274 |
| Pfizer | 11 | $162 |
| Johnson & Johnson | 9 | $138 |
| AbbVie | 5 | $86 |
| Novo Nordisk | 5 | $69 |
| Inspire Medical Systems, Inc. | 1 | $55 |
| Medtronic | 1 | $51 |
| Boston Scientific | 2 | $49 |
| Averitas Pharma Inc. | 2 | $40 |
| AstraZeneca(2 entities) | 2 | $38 |
| Novartis | 3 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Astellas Pharma US Inc | 2 | $37 |
| Bayer | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Boehringer Ingelheim | 1 | $21 |
| Dexcom, Inc. | 1 | $17 |
| GSK | 1 | $12 |
| Daxor Corporation | 1 | $4 |
| Phathom Pharmaceuticals, Inc. | 1 | $3 |
How this compares
$1,193 in reported general payments places this provider in the 60th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Novolog FlexpenInsulin Aspart | 12 | $3,795 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 94 | $1,589 |
| Gabapentin | 61 | $1,302 |
| Atorvastatin Calcium | 73 | $525 |
| Diclofenac Sodium | 11 | $494 |
| Omeprazole | 35 | $381 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 23 | $330 |
| Metoprolol Succinate | 28 | $305 |
| Losartan Potassium | 30 | $287 |
| Amlodipine Besylate | 68 | $269 |
| Pantoprazole Sodium | 25 | $260 |
| Ipratropium Bromide | 16 | $229 |
| Tizanidine Hcl | 23 | $229 |
| Rosuvastatin Calcium | 29 | $228 |
| Tamsulosin Hcl | 28 | $191 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Tupelo
- Jeanne BensonTupelo$13K
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Kristi TrimmRidgeland$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.